{"entity":{"type":"insider","cik":"0002023884","url":"/insider/0002023884","json_url":"/insider/0002023884.json","name":"Waheed Nadia","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2025-06-03","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Waheed Nadia","source":"filing","n_filings":4,"first_seen":"2025-06-03","last_seen":"2026-06-05"}],"transactions":[{"id":6071399,"accession":"0001104659-26-070956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-070956","line_url":"/filing/0001104659-26-070956#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002023884","owner_name":"Waheed Nadia","owner_display_name":"Waheed Nadia","owner_url":"/insider/0002023884","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14828.0,"shares_display":"14,828","price_per_share":8.27,"price_display":"8.27","price_state":"stated","total_value":122627.56,"total_display":"122,627.56","total_whole":"122,628","shares_owned_after":300079.0,"shares_owned_after_display":"300,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-03","filed_date":"2026-06-05","scope":"insider"},{"id":6071049,"accession":"0001104659-26-019257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-019257","line_url":"/filing/0001104659-26-019257#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002023884","owner_name":"Waheed Nadia","owner_display_name":"Waheed Nadia","owner_url":"/insider/0002023884","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3510.0,"shares_display":"3,510","price_per_share":7.74,"price_display":"7.74","price_state":"stated","total_value":27167.4,"total_display":"27,167.40","total_whole":"27,167","shares_owned_after":314907.0,"shares_owned_after_display":"314,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-24","scope":"insider"},{"id":5781469,"accession":"0001104659-26-016665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-016665","line_url":"/filing/0001104659-26-016665#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002023884","owner_name":"Waheed Nadia","owner_display_name":"Waheed Nadia","owner_url":"/insider/0002023884","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7863.0,"shares_display":"7,863","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":71081.52,"total_display":"71,081.52","total_whole":"71,082","shares_owned_after":318417.0,"shares_owned_after_display":"318,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":4955731,"accession":"0001104659-25-055981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-055981","line_url":"/filing/0001104659-25-055981#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0002023884","owner_name":"Waheed Nadia","owner_display_name":"Waheed Nadia","owner_url":"/insider/0002023884","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13861.0,"shares_display":"13,861","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":111581.05,"total_display":"111,581.05","total_whole":"111,581","shares_owned_after":206805.0,"shares_owned_after_display":"206,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2025-06-03","last_seen":"2026-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002023884","retrieved_at":"2026-08-26T19:15:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}